Nuvectis Pharma, Inc. (NVCT) SEC filings
NVCT SEC filings moved a median of -1.15% by the close. NVCT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NVCT overview →
46 measured NVCT SEC filing events.
Where these NVCT SEC filings landedvs 46 measured NVCT SEC filing reactions
| Middle 50% of NVCT SEC filing reactions | -4.51% to +1.83% |
|---|---|
| Median reaction (to close) | -1.15% |
| Measured reactions | 46 |
Point-in-time · zero look-ahead
Half of the 46 NVCT SEC filing events with a measured close landed between -4.51% and +1.83%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT Nuvectis Pharma, Inc. | SEC filing · Form EFFECT | +2.98% | -3.36% | |
| Form 8-K Nuvectis Pharma, Inc. For: Jul 20 | SEC filing · Form 8-K | -0.95% | +1.32% | |
| Form S-3 Nuvectis Pharma, Inc. | SEC filing · Form S-3 | -0.95% | +1.32% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.22% | +4.36% | |
| Form 8-K Nuvectis Pharma, Inc. For: Aug 04 | SEC filing · Form 8-K | -3.22% | +4.36% | |
| Form 8-K Nuvectis Pharma, Inc. For: Jun 29 | SEC filing · Form 8-K | +3.60% | +4.89% | |
| Form 8-K Nuvectis Pharma, Inc. For: Jun 29 | SEC filing · Form 8-K | -1.92% | -11.71% | |
| Form 8-K Nuvectis Pharma, Inc. For: Jun 22 | SEC filing · Form 8-K | +1.81% | +9.48% | |
| Form 8-K Nuvectis Pharma, Inc. For: Jun 11 | SEC filing · Form 8-K | +0.00% | +1.92% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.79% | +9.35% | |
| Form 8-K Nuvectis Pharma, Inc. For: May 05 | SEC filing · Form 8-K | +0.79% | +9.35% | |
| Form DEF 14A Nuvectis Pharma, Inc. For: Jun 11 | SEC filing · Form DEF | +0.00% | -1.25% | |
| Form DEFA14A Nuvectis Pharma, Inc. | SEC filing · Form DEFA14A | +0.00% | -1.25% | |
| Form EFFECT Nuvectis Pharma, Inc. | SEC filing · Form EFFECT | +0.00% | +1.55% | |
| Form S-3 Nuvectis Pharma, Inc. | SEC filing · Form S-3 | -2.30% | +2.88% | |
| Form 10-K Nuvectis Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.13% | -0.79% | |
| Form 8-K Nuvectis Pharma, Inc. For: Feb 11 | SEC filing · Form 8-K | -1.13% | -0.79% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.33% | -5.31% | |
| Form 8-K Nuvectis Pharma, Inc. For: Nov 04 | SEC filing · Form 8-K | -2.33% | -5.31% | |
| Form 8-K Nuvectis Pharma, Inc. For: Sep 22 | SEC filing · Form 8-K | +1.27% | +0.68% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.28% | -3.63% | |
| Form 8-K Nuvectis Pharma, Inc. For: Aug 05 | SEC filing · Form 8-K | +0.28% | -3.63% | |
| Form 8-K Nuvectis Pharma, Inc. For: Jun 12 | SEC filing · Form 8-K | — | +2.73% | |
| Form 8-K Nuvectis Pharma, Inc. For: May 09 | SEC filing · Form 8-K | -3.63% | -6.42% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.21% | -2.88% | |
| Form 8-K Nuvectis Pharma, Inc. For: May 06 | SEC filing · Form 8-K | +0.15% | -6.67% | |
| Form DEF 14A Nuvectis Pharma, Inc. For: Jun 12 | SEC filing · Form DEF | +1.53% | -1.05% | |
| Form DEFA14A Nuvectis Pharma, Inc. | SEC filing · Form DEFA14A | +1.53% | -1.05% | |
| Form 10-K Nuvectis Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +3.23% | -3.79% | |
| Form 8-K Nuvectis Pharma, Inc. For: Feb 25 | SEC filing · Form 8-K | +1.24% | -4.54% | |
| Form 8-K Nuvectis Pharma, Inc. For: Feb 05 | SEC filing · Form 8-K | -0.01% | +1.26% | |
| Form S-8 Nuvectis Pharma, Inc. | SEC filing · Form S-8 | -2.08% | +14.56% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.48% | +19.45% | |
| Form 8-K Nuvectis Pharma, Inc. For: Nov 05 | SEC filing · Form 8-K | +0.48% | +19.45% | |
| Form 8-K Nuvectis Pharma, Inc. For: Aug 29 | SEC filing · Form 8-K | -4.49% | -9.10% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -5.70% | |
| Form 8-K Nuvectis Pharma, Inc. For: Aug 06 | SEC filing · Form 8-K | +0.00% | -5.70% | |
| Form 8-K Nuvectis Pharma, Inc. For: Jun 13 | SEC filing · Form 8-K | +0.38% | +0.30% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -8.14% | |
| Form 8-K Nuvectis Pharma, Inc. For: May 07 | SEC filing · Form 8-K | +1.20% | -4.39% | |
| Form DEF 14A Nuvectis Pharma, Inc. For: Jun 13 | SEC filing · Form DEF | -1.11% | -3.95% | |
| Form DEFA14A Nuvectis Pharma, Inc. | SEC filing · Form DEFA14A | -1.11% | -3.95% | |
| Form 10-K Nuvectis Pharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.69% | -3.44% | |
| Form 8-K Nuvectis Pharma, Inc. For: Mar 05 | SEC filing · Form 8-K | +0.00% | +0.99% | |
| Form 10-Q Nuvectis Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.72% | |
| Form 8-K Nuvectis Pharma, Inc. For: Nov 08 | SEC filing · Form 8-K | +0.00% | -5.72% |
Keep exploring
More NVCT: earnings → · analyst actions → · NVCT overview →